Clarivate Webinar “Intelligence Amplified in the Age of AI” Highlights How Trusted, Proprietary Data Powers Next Generation Innovation
London, UK – February 3, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age of AI, an in‑depth session exploring how Clarivate is leveraging artificial intelligence to reshape research, innovation, and decision‑making across the scientific, academic, intellectual property, and life sciences ecosystems.
Hosted by Matti Shem Tov, Chief Executive Officer of Clarivate, the webinar unveils how Clarivate is applying cutting-edge AI technology to amplify the value of its trusted intelligence, which is built on decades of investment in proprietary content, expert curation, and workflow‑embedded technologies.
“Clarivate is uniquely positioned to thrive in the age of AI,” said Shem Tov. “With 97%[1] of our revenue generated from proprietary solutions, our deep domain expertise, enriched data, and embedded workflows give us a durable foundation that general‑purpose AI models cannot replicate. This webinar demonstrates how our Intelligence Amplified framework strengthens our market position and accelerates customer outcomes across the innovation lifecycle.”
During the session, the Presidents representing each of Clarivate’s three segments—Academia & Government, Intellectual Property, and Life Sciences & Healthcare—demonstrate how the organization’s AI-driven capabilities are currently providing tangible value through the following initiatives:
- AI Research Assistants enabling conversational, contextual discovery grounded in trusted, transparent data sources.
- AI Workflow Agents that automate complex, multi‑step tasks, enhancing accuracy, productivity, and efficiency while keeping expert judgment at the center.
- AI Ecosystem Access, extending Clarivate’s gold‑standard intelligence into customers’ preferred AI environments and models.
The webinar also highlights Clarivate’s unmatched data foundation including billions of expertly curated and enriched records spanning drug safety, patents, regulatory intelligence, academic literature, and more, and how this structured, AI‑ready data dramatically reduces hallucination risks and enables mission‑critical decision‑making in high‑stakes environments.
“AI augments, never replaces, the human expertise and curation that sit at the heart of our intelligence,” Shem Tov added. “Our strategy ensures customers can trust the provenance, accuracy, and reliability of every insight, which is now amplified by the power of AI.”
Webinar Details
The video webinar can be accessed at https://videos.clarivate.com/watch/Ann6g575o9oZMJuWg8VvHW.
Forward-Looking Statements
This release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements” within the meaning of the “safe harbor provisions” of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “seeks,” “projects,” “intends,” “plans,” “may,” “will,” or “should” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts, and include statements regarding our intentions, beliefs, or current expectations concerning, among other things, anticipated cost savings, results of operations, financial condition, liquidity, prospects, growth, strategies, and the markets in which we operate. Such forward-looking statements are based on available current market material and management’s expectations, beliefs, and forecasts concerning future events impacting us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks and uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in Item 1A. Risk Factors in our annual report on Form 10-K, along with our other filings with the U.S. Securities and Exchange Commission (“SEC”). Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Please consult our public filings with the SEC, which are also available on our website at www.clarivate.com.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com.
Investor Relations Contact
Mark Donohue, Vice President, Investor Relations
investor.relations@clarivate.com
Media Contact
Amy Bourke-Waite, Senior Director, Communications & Brand
newsroom@clarivate.com
[1] For the trailing twelve months ended September 30, 2025, excluding disposals. References to proprietary revenue percentage are based on solutions which are materially enhanced by Clarivate’s intellectual property.
